Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy
Identifieur interne : 006B42 ( Main/Merge ); précédent : 006B41; suivant : 006B43Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy
Auteurs : Han-Cheng Wang [Taïwan] ; Yoloung Hsieh [Taïwan]Source :
- Movement Disorders [ 0885-3185 ] ; 2001-07.
Abstract
A 20‐year‐old psychiatric patient receiving haloperidol treatment developed acute‐onset fever, rigidity, and mental changes. Subcutaneous apomorphine was given alone for treatment. The patient had rapid clinical improvement after the treatment. Serial blood examinations showed decline and subsequent normalization of the creatine phosphokinase levels.
Url:
DOI: 10.1002/mds.1133
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001D60
- to stream Istex, to step Curation: 001D60
- to stream Istex, to step Checkpoint: 002E87
Links to Exploration step
ISTEX:DF57C0FFD308C82DDCF23E23CF83808C744EA23DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy</title><author><name sortKey="Wang, Han Heng" sort="Wang, Han Heng" uniqKey="Wang H" first="Han-Cheng" last="Wang">Han-Cheng Wang</name></author><author><name sortKey="Hsieh, Yoloung" sort="Hsieh, Yoloung" uniqKey="Hsieh Y" first="Yoloung" last="Hsieh">Yoloung Hsieh</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:DF57C0FFD308C82DDCF23E23CF83808C744EA23D</idno><date when="2001" year="2001">2001</date><idno type="doi">10.1002/mds.1133</idno><idno type="url">https://api.istex.fr/document/DF57C0FFD308C82DDCF23E23CF83808C744EA23D/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001D60</idno><idno type="wicri:Area/Istex/Curation">001D60</idno><idno type="wicri:Area/Istex/Checkpoint">002E87</idno><idno type="wicri:doubleKey">0885-3185:2001:Wang H:treatment:of:neuroleptic</idno><idno type="wicri:Area/Main/Merge">006B42</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy</title><author><name sortKey="Wang, Han Heng" sort="Wang, Han Heng" uniqKey="Wang H" first="Han-Cheng" last="Wang">Han-Cheng Wang</name><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Neurology, Shin Kong Wu Ho‐Su Memorial Hospital, Taipei</wicri:regionArea><wicri:noRegion>Taipei</wicri:noRegion></affiliation></author><author><name sortKey="Hsieh, Yoloung" sort="Hsieh, Yoloung" uniqKey="Hsieh Y" first="Yoloung" last="Hsieh">Yoloung Hsieh</name><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Neurology, Shin Kong Wu Ho‐Su Memorial Hospital, Taipei</wicri:regionArea><wicri:noRegion>Taipei</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><date type="published" when="2001-07">2001-07</date><biblScope unit="vol">16</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="765">765</biblScope><biblScope unit="page" to="767">767</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">DF57C0FFD308C82DDCF23E23CF83808C744EA23D</idno><idno type="DOI">10.1002/mds.1133</idno><idno type="ArticleID">MDS1133</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A 20‐year‐old psychiatric patient receiving haloperidol treatment developed acute‐onset fever, rigidity, and mental changes. Subcutaneous apomorphine was given alone for treatment. The patient had rapid clinical improvement after the treatment. Serial blood examinations showed decline and subsequent normalization of the creatine phosphokinase levels.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006B42 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 006B42 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Merge
|type= RBID
|clé= ISTEX:DF57C0FFD308C82DDCF23E23CF83808C744EA23D
|texte= Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy
}}
| This area was generated with Dilib version V0.6.23. |  |